Day: March 18, 2021

Timing and dosing are the key to HCQ + AZ treatment in elderly Covid-19 patients

Antiviral therapy is only of interest during the early and intermediate viral phase when the virus is present and replicates, and is of no use during the late inflammatory phase (cytokine storm). Most therapeutic trials, unfortunately, have been carried out in hospitalized patients, which is to say probably often too late, because the patients are in the early inflammatory phase.

Read More »